Fig. 1From: A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapyThe inclusion/exclusion process and outline of the treatment patterns post PARPi maintenance therapyBack to article page